Intuitive, integrated and efficient – world premiere of the next-generation Philips Azurion image-guided therapy platform #ImageGuidedTherapy #MinimallyInvasive Read more: to.philips/6019GU9uL

#DEFINEPCI study 1-yr data demonstrate the potential of treating residual ischemia to improve clinical outcomes for coronary stent patients. Read the news: to.philips/6010G4Rfk

DEFINE-PCI late breaking science at #TCT2020. Post successful PCI iFR <0.95 (present in 295/467 pts – 31%) was associated with incr cardiac death or spontaneous MI, and trend toward more angina at 1 year Perfect set-up for large pivotal DEFINE-GPS RCT.

Breaking at #TCTConnect: DEFINE PCI 1 yr data demonstrates 68% relative reduction in clinical events among patients achieving post-PCI #iFR ≥ 0.95! Watch for panel discussion on Fri Oct 16, 8aET-> tctconnect.com #physiology #cardiotwitter #OmniWire PhilipsLiveFrom

New data just released at #TCTConnect suggests that PCI guided by #iFR co-registered on an angiogram may improve outcomes and reduce angina for patients-- more effectively than treatment guided by angio alone. Recap from Allen Jeremias below. Philips Healthcare #iFR #cardiotwitter

Are We Using Physiology the Wrong Way? A Discussion of the DEFINE PCI One-Year Results Register at #TCTConnect2020 for the expert discussion on the Define PCI 1 year results, today 8 am EDT tctconnect.com

#DEFINEPCI 1-yr data shows 68% reduction in adverse events with post-PCI iFR ≥ 0.95 Excited for the LIVE Q&A Thursday Oct 22,6-7pm EST with @ajaykirtane Gregg W. Stone MD Manesh Patel Allen Jeremias #DEFINEPCI investigators #Cardiotwitter #physiology #cardiology #PCI #Ischemia

Philips CEO Frans van Houten: I am pleased that, under challenging circumstances, we have been able to execute our plans and return to growth and improved profitability for the Group in the third quarter. Read more: to.philips/6014Gf3xq

Philips provides new financial targets for accelerated growth, higher profitability and improved cash flow for the 2021–2025. Read more: to.philips/6019Gf30B

Philips CEO Frans van Houten: Our strategy to transform care along the health continuum strongly resonates with customers and has been further validated during the COVID-19 pandemic. Read more: to.philips/6011GfOnW

Last week DEFINE PCI 1-year data was released at #TCTConnect watch the panel discussion again: spr.ly/6014GfR9A. Join the live Twitter Q&A with the #DEFINEPCI investigators Thursday, Oct. 22 @ 6pm-7pm ET

DEFINE PCI 1-year data: Are we using #physiology the right way? Join the live Twitter Q&A and discussion with the #DEFINEPCI study investigators Thursday, Oct. 22 @ 6pm-7pm ET

WATCH: Philips CEO Frans van Houten on Bloomberg TV discussing Q3 results and more to.philips/6014GAJoj #healthtech

Had a great time helping Bert van Meurs share our Image Guided Therapy strategic update with institutional investors and analysts during Philips Capital Markets Day. See (and hear) the full webcast here: philips.com/a-w/about/inve… Philips News Philips Healthcare

Meta-analysis further confirms safety profile of our Stellarex DCB #VIVA2020 philips.com/a-w/about/news…

ClarifEye Augmented Reality Surgical Navigation - News | Philips philips.com/a-w/about/news…

Philips is accepting submissions for a first-ever Peripheral Vascular Intervention Fellowship Program! Submit a 15min presentation on this year’s topic: “How #IVUS allows us to see clearly and treat optimally in art or venous procedures.” Details here-> philips.to/2NiOjH2

Today we used Fiber Optic Real Shape (FORS) instead of XRAY for vessel cannulation during 4 vessel FEVAR for first time in US. First step towards achieving our goal of FEVAR without radiation. Safer for patients, safer for providers. UMass Memorial Health @UMassMedical Society for Vascular Surgery

Philips announces positive two-year data from TOBA II BTK clinical trial vascularnews.com/philips-announ…

Thank you Philips Healthcare for meeting us in San Diego and discussing life sciences & health innovation and the image-guided surgery market. With a strong presence in California, Philips is a great example of Dutch biotech and healthcare excellence in the United States.